Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 million doses, says Government

As communicated by the Serum Institute of India (SII), the current monthly production capacity of anti-COVID vaccine Covishield is 250-275 million doses, the government informed Lok Sabha recently.

Further, as communicated by Bharat Biotech, Hyderabad, the current monthly production capacity of Covaxin is 50-60 million doses, Bharati Pravin Pawar, Minister of State for Health, said in a written reply.

Responding to a question on whether the government has ascertained if the two approved COVID-19 vaccine manufacturers have achieved optimum production capacity, Pawar said, “Both companies have achieved close to 90 per cent of present production capacity.”